Institutions / Samsara BioCapital, LLC
Samsara BioCapital, LLC
CIK 1744967 · Institution · as of Dec 31, 2025
Portfolio value
$969.26M
Positions
21
As of
Dec 31, 2025
Top holdings
Dec 31, 2025
| Company | Value | % of portfolio |
|---|---|---|
| Scholar Rock Holding Corp | $303.84M | 31.3% |
| Mineralys Therapeutics IncMLYS | $213.06M | 22.0% |
| Kalaris Therapeutics, Inc.KLRS | $109.28M | 11.3% |
| Septerna, Inc.SEPN | $87.80M | 9.1% |
| Alumis Inc.ALMS | $56.19M | 5.8% |
| Neurogene Inc.NGNE | $35.37M | 3.6% |
| Inventiva SA | $24.16M | 2.5% |
| Gossamer Bio, Inc. | $22.39M | 2.3% |
| Upstream Bio, Inc.UPB | $19.98M | 2.1% |
| Aquestive Therapeutics, Inc.AQST | $16.15M | 1.7% |
| Jade Biosciences, Inc. | $14.95M | 1.5% |
| vTv Therapeutics Inc. | $11.94M | 1.2% |
| Rani Therapeutics Holdings, Inc. | $11.47M | 1.2% |
| Palvella Therapeutics, Inc.PVLA | $10.97M | 1.1% |
| Abivax SA | $10.17M | 1.0% |
| X4 Pharmaceuticals, Inc | $7.84M | 0.8% |
| Nkarta, Inc.NKTX | $6.49M | 0.7% |
| Arcellx, Inc. | $3.97M | 0.4% |
| Sutro Biopharma, Inc. | $2.37M | 0.2% |
| Contineum Therapeutics, Inc. | $825.8K | 0.1% |
| Nuvation Bio Inc | $41.0K | 0.0% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.